TickerFacts.

Edwards Lifesciences Corp (EW): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.33B
Year ended 2025-12-31
$1.43B
Trailing 12 months to 2026-06-30
+11.1%
3-year compound annual growth
+15.6%
5-year compound annual growth
+11.6%
10-year compound annual growth
$1.41B2008-12-31: $102.60M2009-12-31: $101.30M2010-12-31: $189.60M2011-12-31: $231.60M2012-12-31: $253.10M2013-12-31: $363.70M2014-12-31: $939.40M2015-12-31: $447.00M2016-12-31: $528.30M2017-12-31: $832.60M2018-12-31: $688.00M2019-12-31: $928.50M2020-12-31: $647.30M2021-12-31: $1.41B2022-12-31: $973.60M2023-12-31: $642.80M2024-12-31: $289.90M2025-12-31: $1.33B$1.33B
2008-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$1.33B+360.5%2026-02-25, From 2025-01-01
2024-12-31$289.90M-54.9%2026-02-25, From 2024-01-01
2023-12-31$642.80M-34.0%2026-02-25, From 2023-01-01
2022-12-31$973.60M-30.8%2025-02-28, From 2022-01-01
2021-12-31$1.41B+117.3%2024-02-12, From 2021-01-01
2020-12-31$647.30M-30.3%2023-02-13, From 2020-01-01
2019-12-31$928.50M+35.0%2022-02-14, From 2019-01-01
2018-12-31$688.00M-17.4%2021-02-12, From 2018-01-01
2017-12-31$832.60M+57.6%2020-02-14, From 2017-01-01
2016-12-31$528.30M+18.2%2019-02-15, From 2016-01-01
2015-12-31$447.00M-52.4%2018-02-16, From 2015-01-01
2014-12-31$939.40M+158.3%2017-02-17, From 2014-01-01
2013-12-31$363.70M+43.7%2016-02-19, From 2013-01-01
2012-12-31$253.10M+9.3%2015-02-20, From 2012-01-01
2011-12-31$231.60Mn/c2014-02-28, From 2011-01-01
2010-12-31$189.60M+87.2%2013-02-28, From 2010-01-01
2009-12-31$101.30M-1.3%2012-02-27, From 2009-01-01
2008-12-31$102.60Mn/a2011-02-28, From 2008-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Edwards Lifesciences Corp (EW)2025-12-31$1.33B+360.5%
Steris PLC (STE)2026-03-31$972.40M+25.0%
Zimmer Biomet Holdings, Inc. (ZBH)2025-12-31$1.47B+13.7%
Align Technology Inc (ALGN)2025-12-31$490.78M-21.2%
Intuitive Surgical Inc (ISRG)2025-12-31$2.49B+91.0%
Enovis Corp (ENOV)2025-12-31$19.92Mn/m
MSA Safety Inc (MSA)2025-12-31$295.43M+22.0%
Cadre Holdings, Inc. (CDRE)2025-12-31$56.85M+117.7%
Inogen Inc (INGN)2025-12-31-$13.74Mn/m

Compare EW, STE, ZBH, ALGN side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗